Logo
x

Search

Subscribe Now

two

Amgen Reports Results of Blincyto (blinatumomab) in P-III Study for Relapsed Acute Lymphoblastic Leukemia in Pediatric Patients

Amgen Reports Results of Blincyto (blinatumomab) in P-III Study for Relapsed Acute Lymphoblastic Leukemia in Pediatric Patients

  • March 3, 2021
EMA's CHMP Recommends the Approval of Two Bevacizumab Biosimilars

EMA's CHMP Recommends the Approval of Two Bevacizumab Biosimilars

  • January 28, 2021
Roche Reports Results of Faricimab in Two Global P-III Studies for Diabetic Macular Edema

Roche Reports Results of Faricimab in Two Global P-III Studies for Diabetic Macular Edema

  • December 22, 2020
Novartis Signs an Option and License Agreement with Molecular Partners to Develop Two DARPin Therapies for COVID-19

Novartis Signs an Option and License Agreement with Molecular Partners to Develop Two DARPin Therapies for COVID-19

  • October 28, 2020
Samsung Bioepis Reports Results of Renflexis (biosimilar- infliximab) from Two Studies in IBD Patients

Samsung Bioepis Reports Results of Renflexis (biosimilar- infliximab) from Two Studies in IBD Patients

  • October 27, 2020
Jazz Collaborates with Redx Pharma to Develop Two Targeted Cancer Therapies

Jazz Collaborates with Redx Pharma to Develop Two Targeted Cancer Therapies

  • September 10, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.